deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 4-arm NCT04359095

Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia

Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia: A Pragmatic Randomized Controlled Trial

Sponsor: Clínica Colsanitas-Clínica Universitaria Colombia

Conditions COVID-19
Interventions Colchicine Pill Emtricitabine/tenofovir Rosuvastatin Standard treatment
Updated 9 times since 2020 Last updated: Aug 4, 2021 Started: Aug 18, 2020 Primary completion: Mar 20, 2021 Completion: Jun 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04359095, this PHASE2/PHASE3 trial focuses on COVID-19 and remains completed. Sponsored by Clínica Colsanitas-Clínica Universitaria Colombia, it has been updated 9 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~May 2020 – ~Oct 2020 · 5 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Jun 2021 · 3 months · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

    Status: Recruiting → Completed

  5. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE2_PHASE3

▶ Show 4 earlier versions

  1. Mar 2021 — Jun 2021 [monthly]

    Recruiting PHASE2_PHASE3

  2. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2_PHASE3

  3. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Not Yet Recruiting → Recruiting

  4. May 2020 — Oct 2020 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clínica Colsanitas-Clínica Universitaria Colombia
  • Clínica Infantil Santa María del Lago
  • Fundación Cardioinfantil Instituto de Cardiología
  • Hospital Universitario Nacional de Colombia (HUN)
  • Hospital Universitario San Ignacio
  • Pontificia Universidad Javeriana
  • Universidad Nacional de Colombia
Data source: Universidad Nacional de Colombia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations